Royal London Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $66.3M | Sell |
|
|||||
|
2025
Q2 | $74.1M | Sell |
|
|||||
|
2025
Q1 | $71.6M | Buy |
|
|||||
|
2024
Q4 | $56.5M | Sell |
|
|||||
|
2024
Q3 | $53.2M | Buy |
|
|||||
|
2024
Q2 | $47.2M | Buy |
|
|||||
|
2024
Q1 | $41.8M | Buy |
|
|||||
|
2023
Q4 | $34.4M | Buy |
|
|||||
|
2023
Q3 | $30.3M | Buy |
|
|||||
|
2023
Q2 | $29.2M | Buy |
|
|||||
|
2023
Q1 | $25.4M | Sell |
|
|||||
|
2022
Q4 | $23.7M | Buy |
|
|||||
|
2022
Q3 | $19.6M | Sell |
|
|||||
|
2022
Q2 | $19M | Buy |
|
|||||
|
2022
Q1 | $22.2M | Buy |
|
|||||
|
2021
Q4 | $19.9M | Sell |
|
|||||
|
2021
Q3 | $21.6M | Sell |
|
|||||
|
2021
Q2 | $22.9M | Hold |
|
|||||
|
2021
Q1 | $20.7M | Buy |
|
|||||
|
2020
Q4 | $18.6M | Sell |
|
|||||
|
2020
Q3 | $19.8M | Sell |
|
|||||
|
2020
Q2 | $18.3M | Sell |
|
|||||
|
2020
Q1 | $17.1M | Sell |
|
|||||
|
2019
Q4 | $24.8M | Buy |
|
|||||
|
2019
Q3 | $22.1M | Buy |
|
|||||
|
2019
Q2 | $22.7M | Sell |
|
|||||
|
2019
Q1 | $21.6M | Sell |
|
|||||
|
2018
Q4 | $20.5M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $18.8M | Buy |
|
|||||
|
2016
Q2 | $10.5M | Sell |
|
|||||
|
2016
Q1 | $325K | Buy |
|
|||||
|
2015
Q4 | $8.91M | Buy |
|
|||||
|
2015
Q3 | $7.86M | Buy |
|
|||||
|
2014
Q4 | $56.7K | Buy |
|
|||||
|
2014
Q3 | $3.89M | Buy |
|
|||||
|
2014
Q2 | $4.02M | Sell |
|
|||||
|
2014
Q1 | $4.06M | Sell |
|
|||||
|
2013
Q4 | $4.3M | Buy |
|
|||||
|
2013
Q3 | $3.76M | Hold |
|
|||||
|
2013
Q2 | $3.01M | Buy |
|